NO810834L - Fremgangsmaate til fremstilling av pyrazolpyridinderivater - Google Patents
Fremgangsmaate til fremstilling av pyrazolpyridinderivaterInfo
- Publication number
- NO810834L NO810834L NO810834A NO810834A NO810834L NO 810834 L NO810834 L NO 810834L NO 810834 A NO810834 A NO 810834A NO 810834 A NO810834 A NO 810834A NO 810834 L NO810834 L NO 810834L
- Authority
- NO
- Norway
- Prior art keywords
- pyridinyl
- methyl
- nicotinonitrile
- pyrazolo
- pyridin
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- -1 2,3-dihydroxypropyl Chemical group 0.000 claims description 55
- 150000003839 salts Chemical class 0.000 claims description 35
- 239000002253 acid Substances 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 29
- YYWUUBRRAZTHJK-UHFFFAOYSA-N 2-chloro-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=NC=C1C1=CC=NC=C1 YYWUUBRRAZTHJK-UHFFFAOYSA-N 0.000 claims description 15
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 239000012458 free base Substances 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- GBHCABUWWQUMAJ-UHFFFAOYSA-N 2-hydrazinoethanol Chemical compound NNCCO GBHCABUWWQUMAJ-UHFFFAOYSA-N 0.000 claims description 5
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims description 5
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 150000005229 pyrazolopyridines Chemical class 0.000 claims description 3
- PDDJLINWLJPTAT-UHFFFAOYSA-N 2-(2h-pyridin-1-yl)ethanol Chemical compound OCCN1CC=CC=C1 PDDJLINWLJPTAT-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 57
- 239000000203 mixture Substances 0.000 description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 10
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 230000003177 cardiotonic effect Effects 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- FBLVQXITSLUNLI-UHFFFAOYSA-N 1-pyridin-4-ylbutan-2-one Chemical compound CCC(=O)CC1=CC=NC=C1 FBLVQXITSLUNLI-UHFFFAOYSA-N 0.000 description 5
- SEQOYYYZFNJQSV-UHFFFAOYSA-N 2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)NC=C1C1=CC=NC=C1 SEQOYYYZFNJQSV-UHFFFAOYSA-N 0.000 description 5
- QEJJLSDONYSIPV-UHFFFAOYSA-N 4-(dimethylamino)-3-pyridin-4-ylbut-3-en-2-one Chemical class CN(C)C=C(C(C)=O)C1=CC=NC=C1 QEJJLSDONYSIPV-UHFFFAOYSA-N 0.000 description 5
- LPKOXKULJTZEBH-UHFFFAOYSA-N 5-pyridin-4-yl-2h-pyrazolo[3,4-b]pyridin-3-amine Chemical compound C1=C2C(N)=NNC2=NC=C1C1=CC=NC=C1 LPKOXKULJTZEBH-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- PZRHRDRVRGEVNW-UHFFFAOYSA-N milrinone Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C PZRHRDRVRGEVNW-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- CUYKNJBYIJFRCU-UHFFFAOYSA-N pyridine-3-amine Natural products NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- ILRVKOYYFFNXDB-UHFFFAOYSA-N 1-pyridin-4-ylpropan-2-one Chemical class CC(=O)CC1=CC=NC=C1 ILRVKOYYFFNXDB-UHFFFAOYSA-N 0.000 description 4
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- BTANRVKWQNVYAZ-UHFFFAOYSA-N Sec-butyl alcohol Natural products CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- 210000003540 papillary muscle Anatomy 0.000 description 4
- UVRQQZNBXZMDSZ-UHFFFAOYSA-N 1-methyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(C)N=C(N)C2=CC=1C1=CC=NC=C1 UVRQQZNBXZMDSZ-UHFFFAOYSA-N 0.000 description 3
- YKPPYHQDYGYURG-UHFFFAOYSA-N 2-(3-amino-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-1-yl)ethanol Chemical compound C1=C2C(N)=NN(CCO)C2=NC=C1C1=CC=NC=C1 YKPPYHQDYGYURG-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000000496 cardiotonic agent Substances 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- RMGXLISCRGEXRK-UHFFFAOYSA-N 1-(dimethylamino)-2-(2-methylpyridin-4-yl)pent-1-en-3-one Chemical compound CCC(=O)C(=CN(C)C)C1=CC=NC(C)=C1 RMGXLISCRGEXRK-UHFFFAOYSA-N 0.000 description 2
- RRCWGMDIRDYZOA-UHFFFAOYSA-N 1-(dimethylamino)-2-pyridin-3-ylpent-1-en-3-one Chemical compound CCC(=O)C(=CN(C)C)C1=CC=CN=C1 RRCWGMDIRDYZOA-UHFFFAOYSA-N 0.000 description 2
- IHULZAIPTINOJE-UHFFFAOYSA-N 1-(dimethylamino)-2-pyridin-4-ylhex-1-en-3-one Chemical compound CCCC(=O)C(=CN(C)C)C1=CC=NC=C1 IHULZAIPTINOJE-UHFFFAOYSA-N 0.000 description 2
- SEFCNLNRZRRAQQ-UHFFFAOYSA-N 1-(dimethylamino)-2-pyridin-4-ylpent-1-en-3-one Chemical compound CCC(=O)C(=CN(C)C)C1=CC=NC=C1 SEFCNLNRZRRAQQ-UHFFFAOYSA-N 0.000 description 2
- CQVKMVQRSNNAGO-UHFFFAOYSA-N 2-[4-formyl-3-methyl-n-(2-methylsulfonyloxyethyl)anilino]ethyl methanesulfonate Chemical compound CC1=CC(N(CCOS(C)(=O)=O)CCOS(C)(=O)=O)=CC=C1C=O CQVKMVQRSNNAGO-UHFFFAOYSA-N 0.000 description 2
- FBOSMGHOZBYAAC-UHFFFAOYSA-N 2-bromo-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(Br)=NC=C1C1=CC=NC=C1 FBOSMGHOZBYAAC-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 108010017443 B 43 Proteins 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 125000005680 ethenylethyl group Chemical group [H]C([H])=C([H])C([H])([H])C([H])([H])* 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- JYCCPFNILNBDIW-UHFFFAOYSA-N 1,6-diethyl-5-(2-methylpyridin-4-yl)pyrazolo[3,4-b]pyridin-3-amine Chemical compound CCC1=NC=2N(CC)N=C(N)C=2C=C1C1=CC=NC(C)=C1 JYCCPFNILNBDIW-UHFFFAOYSA-N 0.000 description 1
- FTCZCSXMFOEWTL-UHFFFAOYSA-N 1,6-dimethyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound CC1=NC=2N(C)N=C(N)C=2C=C1C1=CC=NC=C1 FTCZCSXMFOEWTL-UHFFFAOYSA-N 0.000 description 1
- OLGAQBCAUMRNJD-UHFFFAOYSA-N 1-(2-methoxyethyl)-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CCOC)N=C(N)C2=CC=1C1=CC=NC=C1 OLGAQBCAUMRNJD-UHFFFAOYSA-N 0.000 description 1
- MEXKUMJAUDSDEO-UHFFFAOYSA-N 1-(2-methylpropyl)-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CC(C)C)N=C(N)C2=CC=1C1=CC=NC=C1 MEXKUMJAUDSDEO-UHFFFAOYSA-N 0.000 description 1
- XGPYMCTUSLOQOZ-UHFFFAOYSA-N 1-(2-methylpyridin-4-yl)butan-2-one Chemical compound CCC(=O)CC1=CC=NC(C)=C1 XGPYMCTUSLOQOZ-UHFFFAOYSA-N 0.000 description 1
- LZOLWJJOWIUBST-UHFFFAOYSA-N 1-(3-methoxypropyl)-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CCCOC)N=C(N)C2=CC=1C1=CC=NC=C1 LZOLWJJOWIUBST-UHFFFAOYSA-N 0.000 description 1
- FDIWREYUTKFNPH-UHFFFAOYSA-N 1-(dimethylamino)-2-pyridin-4-ylhept-1-en-3-one Chemical compound CCCCC(=O)C(=CN(C)C)C1=CC=NC=C1 FDIWREYUTKFNPH-UHFFFAOYSA-N 0.000 description 1
- HVHPLFOPBATTFX-UHFFFAOYSA-N 1-(dimethylamino)-2-pyridin-4-yloct-1-en-3-one Chemical compound CCCCCC(=O)C(=CN(C)C)C1=CC=NC=C1 HVHPLFOPBATTFX-UHFFFAOYSA-N 0.000 description 1
- DNJOOBFYZIKSTI-UHFFFAOYSA-N 1-(dimethylamino)-4,4-dimethyl-2-pyridin-4-ylpent-1-en-3-one Chemical compound CN(C)C=C(C(=O)C(C)(C)C)C1=CC=NC=C1 DNJOOBFYZIKSTI-UHFFFAOYSA-N 0.000 description 1
- WBLINNRMJUHAIR-UHFFFAOYSA-N 1-(dimethylamino)-4-methyl-2-pyridin-4-ylpent-1-en-3-one Chemical compound CC(C)C(=O)C(=CN(C)C)C1=CC=NC=C1 WBLINNRMJUHAIR-UHFFFAOYSA-N 0.000 description 1
- DTQAZVDPGBRMOX-UHFFFAOYSA-N 1-(dimethylamino)-5-methyl-2-pyridin-4-ylhex-1-en-3-one Chemical compound CC(C)CC(=O)C(=CN(C)C)C1=CC=NC=C1 DTQAZVDPGBRMOX-UHFFFAOYSA-N 0.000 description 1
- JOYQMJIUSGRFDS-UHFFFAOYSA-N 1-butan-2-yl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(C(C)CC)N=C(N)C2=CC=1C1=CC=NC=C1 JOYQMJIUSGRFDS-UHFFFAOYSA-N 0.000 description 1
- FQORDASLMUCPGM-UHFFFAOYSA-N 1-butyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CCCC)N=C(N)C2=CC=1C1=CC=NC=C1 FQORDASLMUCPGM-UHFFFAOYSA-N 0.000 description 1
- BZIZDLSAOAGYIX-UHFFFAOYSA-N 1-ethyl-5-(5-methylpyridin-3-yl)pyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CC)N=C(N)C2=CC=1C1=CN=CC(C)=C1 BZIZDLSAOAGYIX-UHFFFAOYSA-N 0.000 description 1
- HIJDKZRPRJMTJJ-UHFFFAOYSA-N 1-ethyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CC)N=C(N)C2=CC=1C1=CC=NC=C1 HIJDKZRPRJMTJJ-UHFFFAOYSA-N 0.000 description 1
- MEMIURBAUVYGCJ-UHFFFAOYSA-N 1-ethyl-6-methyl-5-pyridin-3-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound CC=1N=C2N(CC)N=C(N)C2=CC=1C1=CC=CN=C1 MEMIURBAUVYGCJ-UHFFFAOYSA-N 0.000 description 1
- AASVZIYPSFSSQZ-UHFFFAOYSA-N 1-hexyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CCCCCC)N=C(N)C2=CC=1C1=CC=NC=C1 AASVZIYPSFSSQZ-UHFFFAOYSA-N 0.000 description 1
- KPDLJESOGUOKGT-UHFFFAOYSA-N 1-methyl-6-pentyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound CCCCCC1=NC=2N(C)N=C(N)C=2C=C1C1=CC=NC=C1 KPDLJESOGUOKGT-UHFFFAOYSA-N 0.000 description 1
- SGEDVOXNYZLYCT-UHFFFAOYSA-N 1-propan-2-yl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(C(C)C)N=C(N)C2=CC=1C1=CC=NC=C1 SGEDVOXNYZLYCT-UHFFFAOYSA-N 0.000 description 1
- GGBZMRMRSILMLI-UHFFFAOYSA-N 1-propyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound C=1N=C2N(CCC)N=C(N)C2=CC=1C1=CC=NC=C1 GGBZMRMRSILMLI-UHFFFAOYSA-N 0.000 description 1
- WMTHSBOLQVKBQL-UHFFFAOYSA-N 1-pyridin-3-ylbutan-2-one Chemical compound CCC(=O)CC1=CC=CN=C1 WMTHSBOLQVKBQL-UHFFFAOYSA-N 0.000 description 1
- WPDJRDYNRNXPBX-UHFFFAOYSA-N 1-pyridin-3-ylpropan-2-one Chemical compound CC(=O)CC1=CC=CN=C1 WPDJRDYNRNXPBX-UHFFFAOYSA-N 0.000 description 1
- BHNLIJUTIBWZRE-UHFFFAOYSA-N 1-pyridin-4-ylheptan-2-one Chemical compound CCCCCC(=O)CC1=CC=NC=C1 BHNLIJUTIBWZRE-UHFFFAOYSA-N 0.000 description 1
- BIQVLKBPKYAXKA-UHFFFAOYSA-N 1-pyridin-4-ylhexan-2-one Chemical compound CCCCC(=O)CC1=CC=NC=C1 BIQVLKBPKYAXKA-UHFFFAOYSA-N 0.000 description 1
- HHKKDDOOJGFETF-UHFFFAOYSA-N 1-pyridin-4-ylpentan-2-one Chemical compound CCCC(=O)CC1=CC=NC=C1 HHKKDDOOJGFETF-UHFFFAOYSA-N 0.000 description 1
- GVLRTOYGRNLSDW-UHFFFAOYSA-N 1h-pyrazolo[3,4-b]pyridine Chemical group C1=CC=C2C=NNC2=N1 GVLRTOYGRNLSDW-UHFFFAOYSA-N 0.000 description 1
- IJDUQYDEGHCKAS-UHFFFAOYSA-N 2-(3-amino-6-ethyl-5-pyridin-3-ylpyrazolo[3,4-b]pyridin-1-yl)ethanol Chemical compound CCC1=NC=2N(CCO)N=C(N)C=2C=C1C1=CC=CN=C1 IJDUQYDEGHCKAS-UHFFFAOYSA-N 0.000 description 1
- MQRPWIYXTTVSDR-UHFFFAOYSA-N 2-(3-amino-6-ethyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-1-yl)ethanol Chemical compound CCC1=NC=2N(CCO)N=C(N)C=2C=C1C1=CC=NC=C1 MQRPWIYXTTVSDR-UHFFFAOYSA-N 0.000 description 1
- YIJXXRYBAJXYGO-UHFFFAOYSA-N 2-[3-amino-5-(2,6-dimethylpyridin-4-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanol Chemical compound CC1=NC(C)=CC(C=2C=C3C(N)=NN(CCO)C3=NC=2)=C1 YIJXXRYBAJXYGO-UHFFFAOYSA-N 0.000 description 1
- YYBOEHJXBGSRDI-UHFFFAOYSA-N 2-[3-amino-5-(2-methylpyridin-3-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanol Chemical compound CC1=NC=CC=C1C1=CN=C(N(CCO)N=C2N)C2=C1 YYBOEHJXBGSRDI-UHFFFAOYSA-N 0.000 description 1
- HSQZHVFBPJCOAE-UHFFFAOYSA-N 2-[3-amino-5-(2-methylpyridin-4-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanol Chemical compound C1=NC(C)=CC(C=2C=C3C(N)=NN(CCO)C3=NC=2)=C1 HSQZHVFBPJCOAE-UHFFFAOYSA-N 0.000 description 1
- BIVVTCXRSVSNEE-UHFFFAOYSA-N 2-[3-amino-6-(2-methylpropyl)-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-1-yl]ethanol Chemical compound CC(C)CC1=NC=2N(CCO)N=C(N)C=2C=C1C1=CC=NC=C1 BIVVTCXRSVSNEE-UHFFFAOYSA-N 0.000 description 1
- YWGMWPKWKVFDBB-UHFFFAOYSA-N 2-chloro-5-(2,6-dimethylpyridin-4-yl)pyridine-3-carbonitrile Chemical compound CC1=NC(C)=CC(C=2C=C(C(Cl)=NC=2)C#N)=C1 YWGMWPKWKVFDBB-UHFFFAOYSA-N 0.000 description 1
- BVJGHJNUCUTJTE-UHFFFAOYSA-N 2-chloro-5-(2-methylpyridin-3-yl)pyridine-3-carbonitrile Chemical compound CC1=NC=CC=C1C1=CN=C(Cl)C(C#N)=C1 BVJGHJNUCUTJTE-UHFFFAOYSA-N 0.000 description 1
- GMVUAQMPEFVJQZ-UHFFFAOYSA-N 2-chloro-5-(2-methylpyridin-4-yl)pyridine-3-carbonitrile Chemical compound C1=NC(C)=CC(C=2C=C(C(Cl)=NC=2)C#N)=C1 GMVUAQMPEFVJQZ-UHFFFAOYSA-N 0.000 description 1
- JLFJQKPJHHJKCN-UHFFFAOYSA-N 2-chloro-5-(3-ethylpyridin-4-yl)pyridine-3-carbonitrile Chemical compound CCC1=CN=CC=C1C1=CN=C(Cl)C(C#N)=C1 JLFJQKPJHHJKCN-UHFFFAOYSA-N 0.000 description 1
- JFYLWZRGZZHRCG-UHFFFAOYSA-N 2-chloro-5-(5-methylpyridin-3-yl)pyridine-3-carbonitrile Chemical compound CC1=CN=CC(C=2C=C(C(Cl)=NC=2)C#N)=C1 JFYLWZRGZZHRCG-UHFFFAOYSA-N 0.000 description 1
- QVKJHDGVJXPUEX-UHFFFAOYSA-N 2-chloro-5-pyridin-3-ylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=NC=C1C1=CC=CN=C1 QVKJHDGVJXPUEX-UHFFFAOYSA-N 0.000 description 1
- DTJMEOCVEMEODJ-UHFFFAOYSA-N 2-chloro-6-(2-methylpropyl)-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound CC(C)CC1=NC(Cl)=C(C#N)C=C1C1=CC=NC=C1 DTJMEOCVEMEODJ-UHFFFAOYSA-N 0.000 description 1
- SJJAKNGXEFSNKK-UHFFFAOYSA-N 2-chloro-6-ethyl-5-pyridin-3-ylpyridine-3-carbonitrile Chemical compound CCC1=NC(Cl)=C(C#N)C=C1C1=CC=CN=C1 SJJAKNGXEFSNKK-UHFFFAOYSA-N 0.000 description 1
- JACPQCOVBABJLT-UHFFFAOYSA-N 2-chloro-6-methyl-5-pyridin-3-ylpyridine-3-carbonitrile Chemical compound CC1=NC(Cl)=C(C#N)C=C1C1=CC=CN=C1 JACPQCOVBABJLT-UHFFFAOYSA-N 0.000 description 1
- GXYVAQNLAMMAJZ-UHFFFAOYSA-N 2-chloro-6-pentyl-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound CCCCCC1=NC(Cl)=C(C#N)C=C1C1=CC=NC=C1 GXYVAQNLAMMAJZ-UHFFFAOYSA-N 0.000 description 1
- RRXOWWGHNMNRAK-UHFFFAOYSA-N 2-chloro-6-propan-2-yl-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound CC(C)C1=NC(Cl)=C(C#N)C=C1C1=CC=NC=C1 RRXOWWGHNMNRAK-UHFFFAOYSA-N 0.000 description 1
- DOUYALGHFKFQRH-UHFFFAOYSA-N 2-chloro-6-propyl-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound CCCC1=NC(Cl)=C(C#N)C=C1C1=CC=NC=C1 DOUYALGHFKFQRH-UHFFFAOYSA-N 0.000 description 1
- WIXMPDLXXXOPCB-UHFFFAOYSA-N 2-ethoxyethylhydrazine Chemical compound CCOCCNN WIXMPDLXXXOPCB-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- IBELBRDFPCFICX-UHFFFAOYSA-N 2-methoxyethylhydrazine Chemical compound COCCNN IBELBRDFPCFICX-UHFFFAOYSA-N 0.000 description 1
- NGSOWKPBNFOQCR-UHFFFAOYSA-N 2-methylpropylhydrazine Chemical compound CC(C)CNN NGSOWKPBNFOQCR-UHFFFAOYSA-N 0.000 description 1
- BHXNMSPNBMWKDY-UHFFFAOYSA-N 2-oxo-6-propan-2-yl-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C(C)C BHXNMSPNBMWKDY-UHFFFAOYSA-N 0.000 description 1
- KALBBNASERLKTK-UHFFFAOYSA-N 2-oxo-6-propyl-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CCC KALBBNASERLKTK-UHFFFAOYSA-N 0.000 description 1
- LUAQTQAFUORQHV-UHFFFAOYSA-N 2h-pyrazolo[3,4-b]pyridin-3-amine Chemical compound C1=CC=C2C(N)=NNC2=N1 LUAQTQAFUORQHV-UHFFFAOYSA-N 0.000 description 1
- LHLKBBIYRNFVSS-UHFFFAOYSA-N 3,3-dimethyl-1-pyridin-4-ylbutan-2-one Chemical compound CC(C)(C)C(=O)CC1=CC=NC=C1 LHLKBBIYRNFVSS-UHFFFAOYSA-N 0.000 description 1
- LOVMKMOUIWOAKL-UHFFFAOYSA-N 3-(3-amino-5-pyridin-3-ylpyrazolo[3,4-b]pyridin-1-yl)propane-1,2-diol Chemical compound C1=C2C(N)=NN(CC(O)CO)C2=NC=C1C1=CC=CN=C1 LOVMKMOUIWOAKL-UHFFFAOYSA-N 0.000 description 1
- MNTKGSQDNPHEFZ-UHFFFAOYSA-N 3-(3-amino-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-1-yl)propane-1,2-diol Chemical compound C1=C2C(N)=NN(CC(O)CO)C2=NC=C1C1=CC=NC=C1 MNTKGSQDNPHEFZ-UHFFFAOYSA-N 0.000 description 1
- QSRRXFBOIHWHHQ-UHFFFAOYSA-N 3-(3-amino-6-methyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-1-yl)propane-1,2-diol Chemical compound CC1=NC=2N(CC(O)CO)N=C(N)C=2C=C1C1=CC=NC=C1 QSRRXFBOIHWHHQ-UHFFFAOYSA-N 0.000 description 1
- IROXPADEBAUTFY-UHFFFAOYSA-N 3-(dimethylamino)-4-pyridin-4-ylbut-3-en-2-one Chemical compound CN(C)C(C(C)=O)=CC1=CC=NC=C1 IROXPADEBAUTFY-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WDWSGRIQZMMHSE-UHFFFAOYSA-N 3-hydrazinylpropane-1,2-diol Chemical compound NNCC(O)CO WDWSGRIQZMMHSE-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- RDBUAUMYKXLZHT-UHFFFAOYSA-N 3-methoxypropylhydrazine Chemical compound COCCCNN RDBUAUMYKXLZHT-UHFFFAOYSA-N 0.000 description 1
- VLJOQJQERRBJGD-UHFFFAOYSA-N 3-methyl-1-pyridin-4-ylbutan-2-one Chemical compound CC(C)C(=O)CC1=CC=NC=C1 VLJOQJQERRBJGD-UHFFFAOYSA-N 0.000 description 1
- YTEIHWVCQJZNEN-UHFFFAOYSA-N 3-pyridin-4-ylpyridine Chemical compound C1=CN=CC(C=2C=CN=CC=2)=C1 YTEIHWVCQJZNEN-UHFFFAOYSA-N 0.000 description 1
- QKIKTEFQAORYEL-UHFFFAOYSA-N 4-(dimethylamino)-3-pyridin-3-ylbut-3-en-2-one Chemical compound CN(C)C=C(C(C)=O)C1=CC=CN=C1 QKIKTEFQAORYEL-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- MZJYKQKNTVSUDS-UHFFFAOYSA-N 4-methyl-1-pyridin-4-ylpentan-2-one Chemical compound CC(C)CC(=O)CC1=CC=NC=C1 MZJYKQKNTVSUDS-UHFFFAOYSA-N 0.000 description 1
- UTLAPGQWWXSJTH-UHFFFAOYSA-N 5-(2-methylpyridin-3-yl)-2h-pyrazolo[3,4-b]pyridin-3-amine Chemical compound CC1=NC=CC=C1C1=CN=C(NN=C2N)C2=C1 UTLAPGQWWXSJTH-UHFFFAOYSA-N 0.000 description 1
- IYZZLZWWNMGEFT-UHFFFAOYSA-N 6-(2-methylpropyl)-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CC(C)C IYZZLZWWNMGEFT-UHFFFAOYSA-N 0.000 description 1
- KLCXQJMAABPMIP-UHFFFAOYSA-N 6-butyl-1-methyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound CCCCC1=NC=2N(C)N=C(N)C=2C=C1C1=CC=NC=C1 KLCXQJMAABPMIP-UHFFFAOYSA-N 0.000 description 1
- GBTQVVYUYNOTBX-UHFFFAOYSA-N 6-butyl-2-chloro-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound CCCCC1=NC(Cl)=C(C#N)C=C1C1=CC=NC=C1 GBTQVVYUYNOTBX-UHFFFAOYSA-N 0.000 description 1
- DYBRWHHEPOFFNG-UHFFFAOYSA-N 6-butyl-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CCCC DYBRWHHEPOFFNG-UHFFFAOYSA-N 0.000 description 1
- ZFOGAXJKWRTNCQ-UHFFFAOYSA-N 6-ethyl-1-methyl-5-pyridin-4-ylpyrazolo[3,4-b]pyridin-3-amine Chemical compound CCC1=NC=2N(C)N=C(N)C=2C=C1C1=CC=NC=C1 ZFOGAXJKWRTNCQ-UHFFFAOYSA-N 0.000 description 1
- RFIJPDMIVQAFHX-UHFFFAOYSA-N 6-ethyl-2-oxo-5-pyridin-3-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=NC=CC=2)=C1CC RFIJPDMIVQAFHX-UHFFFAOYSA-N 0.000 description 1
- RWYYNPUQZIPKQN-UHFFFAOYSA-N 6-ethyl-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CC RWYYNPUQZIPKQN-UHFFFAOYSA-N 0.000 description 1
- VROQJHXWYPWUTN-UHFFFAOYSA-N 6-ethyl-5-(2-methylpyridin-4-yl)-2-oxo-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=C(C)N=CC=2)=C1CC VROQJHXWYPWUTN-UHFFFAOYSA-N 0.000 description 1
- HFXSLWPMSHEBFJ-UHFFFAOYSA-N 6-methyl-2-oxo-5-pyridin-3-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=NC=CC=2)=C1C HFXSLWPMSHEBFJ-UHFFFAOYSA-N 0.000 description 1
- XGVZQXPLLLGAPC-UHFFFAOYSA-N 6-methyl-5-pyridin-4-yl-2h-pyrazolo[3,4-b]pyridin-3-amine Chemical compound CC1=NC=2NN=C(N)C=2C=C1C1=CC=NC=C1 XGVZQXPLLLGAPC-UHFFFAOYSA-N 0.000 description 1
- ADCIELHAXYLDCH-UHFFFAOYSA-N 6-propan-2-yl-5-pyridin-4-yl-2h-pyrazolo[3,4-b]pyridin-3-amine Chemical compound CC(C)C1=NC=2NN=C(N)C=2C=C1C1=CC=NC=C1 ADCIELHAXYLDCH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- 229910017909 NH2NH2H2O Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- SFSUYFSIKDDLOL-UHFFFAOYSA-N butan-2-ylhydrazine Chemical compound CCC(C)NN SFSUYFSIKDDLOL-UHFFFAOYSA-N 0.000 description 1
- XKLVLDXNZDIDKQ-UHFFFAOYSA-N butylhydrazine Chemical compound CCCCNN XKLVLDXNZDIDKQ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- WHRIKZCFRVTHJH-UHFFFAOYSA-N ethylhydrazine Chemical compound CCNN WHRIKZCFRVTHJH-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- VKYBUEJAQKBUFU-UHFFFAOYSA-N hexylhydrazine Chemical compound CCCCCCNN VKYBUEJAQKBUFU-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N n-propyl alcohol Natural products CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- KJAQRHMKLVGSCG-UHFFFAOYSA-N propan-2-ylhydrazine Chemical compound CC(C)NN KJAQRHMKLVGSCG-UHFFFAOYSA-N 0.000 description 1
- UKPBXIFLSVLDPA-UHFFFAOYSA-N propylhydrazine Chemical compound CCCNN UKPBXIFLSVLDPA-UHFFFAOYSA-N 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/131,227 US4264603A (en) | 1980-03-17 | 1980-03-17 | 5-(Pyridinyl)-1H-pyrazolo[3,4-b]pyridine-3-amines, their use as cardiotonics and their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO810834L true NO810834L (no) | 1981-09-18 |
Family
ID=22448499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO810834A NO810834L (no) | 1980-03-17 | 1981-03-11 | Fremgangsmaate til fremstilling av pyrazolpyridinderivater |
Country Status (19)
Country | Link |
---|---|
US (1) | US4264603A (sv) |
JP (1) | JPS56142281A (sv) |
KR (1) | KR830005214A (sv) |
AU (1) | AU6826081A (sv) |
BE (1) | BE887890A (sv) |
DE (1) | DE3109768A1 (sv) |
DK (1) | DK114381A (sv) |
ES (1) | ES8202339A1 (sv) |
FI (1) | FI810759L (sv) |
FR (1) | FR2478100A1 (sv) |
GB (1) | GB2071660A (sv) |
IL (1) | IL62295A0 (sv) |
IT (1) | IT1141998B (sv) |
LU (1) | LU83214A1 (sv) |
NL (1) | NL8101217A (sv) |
NO (1) | NO810834L (sv) |
PT (1) | PT72654B (sv) |
SE (1) | SE8101591L (sv) |
ZA (1) | ZA811418B (sv) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361568A (en) * | 1981-04-28 | 1982-11-30 | Sterling Drug Inc. | 5-(Pyridinyl)-1H-pyrazolo[3,4-b]pyridin-3-amines and their cardiotonic use |
US4374141A (en) * | 1981-08-17 | 1983-02-15 | Sterling Drug Inc. | 2-Substituted amino-5-(pyridinyl)-nicotinamides and their cardiotonic use |
EP0200024B1 (de) | 1985-04-30 | 1992-07-01 | ARZNEIMITTELWERK DRESDEN GmbH | 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
DD298781A5 (de) * | 1990-03-09 | 1992-03-12 | Inst Wirkstofforschung | Verfahren zur herstellung von 5,4'-bipyridin-1'-oxiden |
JP4814783B2 (ja) * | 2003-02-27 | 2011-11-16 | パラウ ファルマ、 ソシエダッド アノニマ | ピラゾロピリジン誘導体 |
US20090008238A1 (en) * | 2004-04-09 | 2009-01-08 | The Arizona Bd Of Reg On Behalf Of The Univ Of Az | Transportable gas sterilization unit, disposable gas generator, light activated anti-infective coating and method of disinfection and sterilization using chlorine dioxide |
AR050188A1 (es) * | 2004-08-03 | 2006-10-04 | Uriach Y Compania S A J | Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen |
CN102558044A (zh) * | 2011-12-29 | 2012-07-11 | 方晏燕 | 米力农的结晶方法 |
CN103664773A (zh) * | 2013-12-18 | 2014-03-26 | 南京易亨制药有限公司 | 米力农的制备方法和精制方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3423414A (en) * | 1966-01-13 | 1969-01-21 | Ciba Geigy Corp | Pyrazolopyridines |
DE2160780A1 (de) * | 1971-12-08 | 1973-06-14 | Basf Ag | Pyridino-pyrazole |
DE2232038A1 (de) * | 1972-06-30 | 1974-01-10 | Hoechst Ag | 3-amino-1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine, ihre herstellung und verwendung |
US4004012A (en) * | 1975-10-14 | 1977-01-18 | Sterling Drug Inc. | 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones |
US4072746A (en) * | 1975-10-14 | 1978-02-07 | Sterling Drug Inc. | 3-Amino-5-(pyridinyl)-2(1H)-pyridinones |
US4020072A (en) * | 1976-05-04 | 1977-04-26 | E. R. Squibb & Sons, Inc. | 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines |
-
1980
- 1980-03-17 US US06/131,227 patent/US4264603A/en not_active Expired - Lifetime
-
1981
- 1981-03-04 IL IL62295A patent/IL62295A0/xx unknown
- 1981-03-04 ZA ZA00811418A patent/ZA811418B/xx unknown
- 1981-03-09 FR FR8104624A patent/FR2478100A1/fr not_active Withdrawn
- 1981-03-10 IT IT20271/81A patent/IT1141998B/it active
- 1981-03-11 GB GB8107631A patent/GB2071660A/en not_active Withdrawn
- 1981-03-11 AU AU68260/81A patent/AU6826081A/en not_active Abandoned
- 1981-03-11 NO NO810834A patent/NO810834L/no unknown
- 1981-03-11 BE BE1/10167A patent/BE887890A/fr unknown
- 1981-03-11 FI FI810759A patent/FI810759L/fi not_active Application Discontinuation
- 1981-03-12 NL NL8101217A patent/NL8101217A/nl not_active Application Discontinuation
- 1981-03-12 PT PT72654A patent/PT72654B/pt unknown
- 1981-03-12 LU LU83214A patent/LU83214A1/fr unknown
- 1981-03-12 KR KR1019810000800A patent/KR830005214A/ko unknown
- 1981-03-12 SE SE8101591A patent/SE8101591L/sv not_active Application Discontinuation
- 1981-03-13 DE DE19813109768 patent/DE3109768A1/de not_active Withdrawn
- 1981-03-13 JP JP3641981A patent/JPS56142281A/ja active Pending
- 1981-03-13 DK DK114381A patent/DK114381A/da unknown
- 1981-03-16 ES ES500412A patent/ES8202339A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE887890A (fr) | 1981-09-11 |
DK114381A (da) | 1981-09-18 |
ES500412A0 (es) | 1982-01-16 |
ES8202339A1 (es) | 1982-01-16 |
IL62295A0 (en) | 1981-05-20 |
JPS56142281A (en) | 1981-11-06 |
GB2071660A (en) | 1981-09-23 |
SE8101591L (sv) | 1981-09-18 |
FI810759L (fi) | 1981-09-18 |
ZA811418B (en) | 1982-03-31 |
IT8120271A0 (it) | 1981-03-10 |
AU6826081A (en) | 1981-09-24 |
PT72654B (en) | 1982-03-19 |
PT72654A (en) | 1981-04-01 |
IT1141998B (it) | 1986-10-08 |
FR2478100A1 (fr) | 1981-09-18 |
LU83214A1 (fr) | 1981-10-30 |
NL8101217A (nl) | 1981-10-16 |
US4264603A (en) | 1981-04-28 |
KR830005214A (ko) | 1983-08-03 |
DE3109768A1 (de) | 1981-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO811040L (no) | Diaminopyridiner og fremgangsmaate til deres fremstilling | |
NO175978B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
CA1159061A (en) | 6-(pyridinyl)-3h-imidazo¬4,5-b|pyridines or 6- (pyridinyl)-1h-imidazo¬4,5-b|pyridines, preparation and cardiotonic use | |
NO810834L (no) | Fremgangsmaate til fremstilling av pyrazolpyridinderivater | |
NO802507L (no) | 6-pyridazinoner med kardiotonisk virkning. | |
NO851066L (no) | Pyridinyl-2-pyrimidinaminer egnet som kardiotoniske midler samt fremstilling derav | |
NO820036L (no) | Pyridinyl-substituerte benzimidazolderivater og fremgangsmaate for deres fremstilling | |
US4375467A (en) | 5-(Pyridinyl)-1H-pyrazolo[3,4-b] pyridines and their cardiotonic use | |
US4391811A (en) | 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use | |
US4374141A (en) | 2-Substituted amino-5-(pyridinyl)-nicotinamides and their cardiotonic use | |
US4265895A (en) | 1,2-Dihydro-5-pyridinyl-3H-pyrazolo[3,4-b]pyridin-3-ones and their use as cardiotonics | |
CA1175429A (en) | 1-substituted-3-(substituted - amino)-5-(pyridinyl)- 1h-pyrazolo[3,4-b]pyridines, their preparation and use as cardiotonics | |
US4264612A (en) | Lower-alkyl 2-halo-5-(pyridinyl)nicotinates, their preparation and use as cardiotonics | |
US4305948A (en) | N-Hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide and their cardiotonic use | |
US4590194A (en) | 3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use | |
US4463008A (en) | 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof | |
NO803911L (no) | 3-acylamino-5-(pyridinyl)-2(1h)-pyridinoner og fremgangsmaate til fremstilling derav | |
NO803735L (no) | 6-(pyridinyl)pyridaziner og fremgangsmaate til deres fremstilling | |
US4337253A (en) | 4,5-Dihydro-2-methyl-6-(4-pyridinyl)-3(2H)-pyridazinone and its use as a cardiotonic | |
US4473571A (en) | 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use | |
NO810833L (no) | Fremgangsmaate til fremstilling av pyrazolpyridinoner og pyridinylnikotinater | |
US4339584A (en) | Process for preparing 3-amino-5-(pyridinyl)-2(1H)-pyridinones via N-hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide by reaction with polyphosphoric acid | |
US4362735A (en) | 3-[(3-Oxo-1-butenyl)amino]-5-(pyridinyl)-2(1H)-pyridinones and their cardiotonic use | |
KR850000025B1 (ko) | 2(1h)-피리디논의 제조방법 | |
US4503228A (en) | 2-(Pyridinyl)-4,5,6-pyrimidinetriamines |